1. Diethylstilbestrol, flutamide and their combination impaired the spermatogenesis of male adult zebrafish through disrupting HPG axis, meiosis and apoptosis
   Pan Yin et al, 2017, Aquatic Toxicology CrossRef
2. PSA response to antiandrogen withdrawal: a systematic review and meta-analysis
   Alwin Soo et al, 2021, Prostate Cancer and Prostatic Diseases CrossRef
3. Alternative Antiandrogen Therapy for CRPC
   Takanobu Utsumi et al, 2018, Hormone Therapy and Castration Resistance of Prostate Cancer CrossRef
4. Impact of alternative antiandrogen therapy for Japanese prostate cancer patients in the era of new hormonal therapy
   Wataru Nakata et al, 2020, International Journal of Urology CrossRef
5. Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study
   Taro Iguchi et al, 2019, International Journal of Clinical Oncology CrossRef
6. Comparative assessment of prognostic outcomes between first-generation antiandrogens and novel androgen-receptor-axis-targeted agents in patients with non-metastatic castration-resistant prostate cancer
   Hideaki Miyake et al, 2019, International Journal of Clinical Oncology CrossRef
7. Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial
   Hideaki Miyake et al, 2023, BMJ Open CrossRef
8. Identification of favorable subgroups for alternative anti‑androgen therapy in castration‑resistant prostate cancer
   Kotaro Suzuki et al, 2019, Molecular and Clinical Oncology CrossRef